Press Releases
- Rezolute, Inc. Announces Top-line Results from Phase 1 Trial Evaluating AB101 in Patients with Diabetes
- Rezolute Management to Present at 2020 Biotech Showcase Conference
- Rezolute Appoints Nektar Therapeutics COO & CFO to Its Board of Directors
- Rezolute Management to Present at 2019 BIO Investor Forum Conference
- Rezolute Management to Present at 2019 Canaccord Genuity Growth Conference
- Rezolute Completes $45 Million Investment Round with Full Exercise of $20 Million Option
- Rezolute Announces $25 Million Private Placement -- Potential Total Investment of $45 Million
